2011
DOI: 10.1021/ic1024229
|View full text |Cite
|
Sign up to set email alerts
|

Structure−Activity Relationship of Photocytotoxic Iron(III) Complexes of Modified Dipyridophenazine Ligands

Abstract: Iron(III) complexes [FeL(B)] (1-5) of a tetradentate trianionic phenolate-based ligand (L) and modified dipyridophenazine bases (B), namely, dipyrido-6,7,8,9-tetrahydrophenazine (dpqC in 1), dipyrido[3,2-a:2',3'-c]phenazine-2-carboxylic acid (dppzc in 2), dipyrido[3,2-a:2',3'-c]phenazine-11-sulfonic acid (dppzs in 3), 7-aminodipyrido[3,2-a:2',3'-c]phenazine (dppza in 4) and benzo[i]dipyrido[3,2-a:2',3'-c]phenazine (dppn in 5), have been synthesized and their photocytotoxic properties studied along with their d… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
41
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 63 publications
(41 citation statements)
references
References 53 publications
0
41
0
Order By: Relevance
“…Porphyrin-, phthalocyanine-and other macrocyclic-based photodynamic therapy (PDT) agents have been designed to show strong correlations between the hydrophobicity of the PDT agents and their therapeutic activity [10][11][12][13][14][15][16]. Among metal-based PDT agents, rhodium, ruthenium and iron complexes show strong dependence of biological activity on their molecular structures [17][18][19][20]. Extended planar aromatic ring in the ligands allows better intercalation with DNA [21].…”
Section: Introductionmentioning
confidence: 99%
“…Porphyrin-, phthalocyanine-and other macrocyclic-based photodynamic therapy (PDT) agents have been designed to show strong correlations between the hydrophobicity of the PDT agents and their therapeutic activity [10][11][12][13][14][15][16]. Among metal-based PDT agents, rhodium, ruthenium and iron complexes show strong dependence of biological activity on their molecular structures [17][18][19][20]. Extended planar aromatic ring in the ligands allows better intercalation with DNA [21].…”
Section: Introductionmentioning
confidence: 99%
“…Cisplatin is a well-known non-PDT model complex, therefore under the same experimental conditions; it was evaluated as a reference metallodrug [109,111]. No reduction in the cell viability was observed on photoexposure of the cells in the absence of the complex.…”
Section: Insert Figmentioning
confidence: 99%
“…To tackle metal, it is anticipated to have a reduced metal-induced cellular toxicity [34,35] in comparison to other metal-based complexes. Chakravarty and co-workers have already reported several Fe(III)-based complexes with a dipyrido[3,2-d:2 ,3 -f]quinoxaline [35][36][37] or a dipicolylamine [34,[38][39][40][41][42][43][44][45] moiety as effective PSs. As an impressive example, the Fe(III) complexes 1 was prepared with a dipicolylamine ligand combined with an anthracenyl moiety, which is able to intercalate in the DNA, and a catechol ligand, which promotes an intense ligand-to-metal charge-transfer band in the near IR window (Figure 1).…”
Section: Introductionmentioning
confidence: 99%